Novonesis A/S (Novozymes A/S)

NSIS B

Equity

ISIN DK0060336014 / Valor 14371062

Nasdaq Copenhagen Equities (2026-10-23)

DKK 481.50+0.52%

Novonesis A/S (Novozymes A/S)
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

Novozymes A/S is a Denmark‑based industrial biotechnology company that develops, manufactures and sells enzymes and microbial solutions for industrial customers across sectors including household care, food and beverages, agriculture and animal nutrition, bioenergy, and pulp and paper. Created as a spin‑off from Novo Nordisk in 2000 and listed on Nasdaq Copenhagen, the company combines research-driven product development with global production and commercial operations to supply enzyme formulations and microorganisms used to improve process efficiency, yields and product characteristics. Its business model centers on product sales, application development and partnerships or licensing agreements with manufacturers and brands worldwide, supported by R&D and manufacturing facilities in multiple countries to tailor solutions for industrial applications.

Summarized from source with an LLMView SourceSector: Industrials

Latest Results ():

Summarized from source with an LLMView Source

Key figures

18.0%1Y

72.5%3Y

6.15%5Y

Performance

27.1%1Y

25.1%3Y

27.3%5Y

Volatility